Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-070143

Chief Financial Officer sold 1,926 shares at $7.81 ($15,042)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Trigilio Jeffrey Chief Financial Officer 2023-12-12 Sale −1,926 $7.81 $15,042 86,237 D
Open-market sales · 1,926 sh · avg $7.81 · $15,042
Loading xslF345X05/ownership.xml…